Our analysis of the SMAD4 mutations in these patients using the same primer pairs as those used in the Cancer Hotspot Panel did not identify any germline mutations; however, we are currently discussing whether patients should be tested for germline mutations in genetic counseling. This evidence concerns the gene SMAD4 and cancer.